Patents Assigned to Ethicon, Inc.
  • Patent number: 12778564
    Abstract: A combined powder and liquid delivery device includes a housing having a powder chamber and a liquid chamber. The device includes an applicator tip having a powder delivery channel extending between a proximal end and a distal end of the applicator tip that is in fluid communication with the powder chamber, and a liquid delivery channel that extends from the proximal to the distal end of the applicator tip that is in fluid communication with the liquid chamber. The delivery device includes a powder inlet port in fluid communication with the powder chamber, and a liquid inlet port in fluid communication with the liquid chamber. A powder delivery system is in fluid communication with the powder inlet port, the powder chamber, and the powder delivery channel. A liquid delivery system is in fluid communication with the liquid inlet port, the liquid chamber, and the liquid delivery channel.
    Type: Grant
    Filed: September 10, 2021
    Date of Patent: November 3, 2026
    Assignees: Guangzhou Bioseal Biotech Co., Ltd., Ethicon, Inc.
    Inventors: Shiwei Xie, Jianxin Guo, Yufu Li, Xuelin Guo, Samantha Weber
  • Patent number: 12773471
    Abstract: Disclosed is a sealant, and techniques for making and using the sealant. The sealant may include three components that, when combined, produce the sealant: an electrophilic component, a nucleophilic component, and a doping component. The electrophilic component may include a first electrophilic material having a first functionality of a first reactive group. The nucleophilic component may include a first nucleophilic material having a second functionality of a second reactive group. The doping component may include a second electrophilic material having a third functionality of the first reactive group greater than the first functionality and/or a second nucleophilic material having a fourth functionality of the second reactive group greater than the second functionality. The doping component may be present in an amount sufficient to provide a 2-20% molar contribution of the first reactive group and/or the second reactive group in the sealant.
    Type: Grant
    Filed: March 6, 2023
    Date of Patent: October 27, 2026
    Assignee: Ethicon, Inc.
    Inventor: Salim A. Ghodbane
  • Patent number: 12773470
    Abstract: The present invention provides a tissue sealing plug comprising a substrate comprising foamed gelatin impregnated with polyethylene glycol that is liquid at room temperature, wherein the weight ratio of polyethylene glycol to foamed gelatin in the substrate is about 4:1 to about 6.8:1 and the substrate is substantially free of air, along with methods of using the plug for closing tissue punctures in the lung.
    Type: Grant
    Filed: October 21, 2022
    Date of Patent: October 27, 2026
    Assignee: Ethicon, Inc.
    Inventors: Salim Ghodbane, Sridevi Dhanaraj, Ashley DeAnglis, Guanghui Zhang
  • Patent number: 12773472
    Abstract: The present invention is directed to hemostatic and/or tissue adhesive formulations comprising crosslinked polysaccharide particles that have been oxidized to generate aldehyde- and carboxylic functional moieties therein, and wherein said formulations further contain a buffer that maintains a slightly alkaline environment. These formulations can be applied onto tissue in the form of a powder, paste or patch to effect hemostasis or sealing.
    Type: Grant
    Filed: July 25, 2023
    Date of Patent: October 27, 2026
    Assignee: Ethicon, Inc.
    Inventors: Thomas Weindl, Benjamin Fitz, Gaojie Hu
  • Publication number: 20260295113
    Abstract: The invention relates to biodegradable bilayer sealants for tissue closure. The sealants of the invention are composed of two layers with different compliances. The layer in immediate contact with the tissue has high compliance. The second layer located immediately above the first sealant layer has low compliance, i.e. the sealant is much stiffer. The burst pressure of the bilayer sealants is enhanced relative to either a single layer elastic sealant or a single layer stiff sealant. The improved sealant compositions herein provide a water-tight seal, can access hard to reach tears, be applied in a dry or wet environment, are low-swelling, and can repair a range of incision or tear sizes. The bilayer sealants are particularly useful for sutureless dural closure or as adjuncts to sutured dural closure. Also provided herein are methods of preparing and using the biodegradable sealant compositions.
    Type: Application
    Filed: June 10, 2026
    Publication date: October 1, 2026
    Applicant: Ethicon, Inc.
    Inventors: Salim A. Ghodbane, Sai Veruva, Mark Neubauer
  • Patent number: 12734268
    Abstract: The present invention is directed to compressed hemostatic tablets or forms comprising a fibrous non-woven oxidized cellulose (OC or ORC) multilayer material compressed into a form stable tablet, further comprising calcium salt, with the tablets rapidly expandable on contact with blood or blood plasma. The compressed forms may further comprise a multi-arm PEG-SG and are dimensionally, preferably with regard to length and width, stable for at least 48 hours after compression. In some embodiments, the compressed forms will expand upon contact with blood from 1.5 to 5 times of tablet length in 5 seconds; from 2 to 6 times of tablet length in 20 seconds; and from 3 to 6 times of tablet length in 5 minutes. The compressed forms are effective in hemostasis in heparinized blood.
    Type: Grant
    Filed: November 8, 2022
    Date of Patent: September 15, 2026
    Assignee: Ethicon, Inc.
    Inventors: Yi-Lan Wang, Tien-Jung Lee
  • Patent number: 12721967
    Abstract: A dispensing system includes a hollow tube having an outer wall with an air vent formed in the outer wall. A valve including a flexible flap is disposed inside the tube. The flexible flap, normally biased into a retracted position, is moveable between an extended position for sealing the air vent and the retracted position for unsealing the air vent. A syringe connector interconnects a syringe with the proximal end of the hollow tube and defines a fluid flow path. A flowable viscous fluid is disposed within the syringe. When a syringe plunger is depressed, the flowable viscous fluid is expelled from the syringe and forced through the fluid flow path and into the proximal end of the hollow tube. When the flowable viscous fluid engages the flexible flap, the flexible flap is forced to move into a position that seals the air vent.
    Type: Grant
    Filed: March 16, 2022
    Date of Patent: September 1, 2026
    Assignee: Ethicon, Inc.
    Inventors: Xuelin Guo, Joseph LoRicco, Gabriella Saade, Matthew Chan
  • Patent number: 12714421
    Abstract: An elastic suture needle for passing through a smaller cannula used in minimally invasive surgery includes an elongated body having a proximal end, a distal end, a length extending from the proximal end to the distal end, a top surface extending along the length of the elongated body, and a bottom surface extending along the length of the elongated body. The elongated body has dimensions that are calculated using the equation T/LN<(2*?)/(?E), where T is the thickness of the elongated body, LN is the length of the neutral axis of the elongated body, ? is the yield strength of the elongated body, and E is the Young's modulus of the elongated body. The elongated body is made of stainless steels such as martensitic stainless steels, austenitic stainless steels, martensitic-aged (mar-aged) stainless steels, and stainless steels sold under the registered trademark ETHALLOY® Needle Alloy.
    Type: Grant
    Filed: January 20, 2023
    Date of Patent: August 25, 2026
    Assignee: Ethicon, Inc.
    Inventors: Frank Richard Cichocki, Jr., Christophe Vailhe, Alexander M. Cannara
  • Patent number: 12673129
    Abstract: The invention relates to biodegradable bilayer sealants for tissue closure. The sealants of the invention are composed of two layers with different compliances. The layer in immediate contact with the tissue has high compliance. The second layer located immediately above the first sealant layer has low compliance, i.e. the sealant is much stiffer. The burst pressure of the bilayer sealants is enhanced relative to either a single layer elastic sealant or a single layer stiff sealant. The improved sealant compositions herein provide a water-tight seal, can access hard to reach tears, be applied in a dry or wet environment, are low-swelling, and can repair a range of incision or tear sizes. The bilayer sealants are particularly useful for sutureless dural closure or as adjuncts to sutured dural closure. Also provided herein are methods of preparing and using the biodegradable sealant compositions.
    Type: Grant
    Filed: August 30, 2022
    Date of Patent: July 7, 2026
    Assignee: Ethicon, Inc.
    Inventors: Salim A. Ghodbane, Sai Veruva, Mark Neubauer
  • Patent number: 12672868
    Abstract: The present invention is directed to coated medical devices, such as implantable and coatable devices, such as sutures, with expanded antibacterial properties, handling, knot slide and in-situ performance and processes for their manufacture and use.
    Type: Grant
    Filed: April 27, 2023
    Date of Patent: July 7, 2026
    Assignee: Ethicon, Inc.
    Inventors: Jackie J. Donners, Howard Scalzo, Jr., John Collier, Vedanta Nayak
  • Publication number: 20260183331
    Abstract: The invention relates to a rapid setting liquid lung sealant that forms a highly adherent and elastic hydrogel. Provided are lung sealants comprising two high molecular weight (20 kDa) multi-arm PEG compositions wherein the first PEG composition includes an alkaline buffer and the second PEG composition includes a mildly acidic buffer for optimized set up time and extended working time. In some embodiments, the PEGs further comprise a radioprotectant such as tocopherol. In some embodiments, a colorant is added to one or both PEGs of the lung sealant to improve visualization of the lung sealant against human lung tissue.
    Type: Application
    Filed: October 28, 2025
    Publication date: July 2, 2026
    Applicant: Ethicon, Inc.
    Inventors: Salim A. Ghodbane, Sridevi Dhanaraj, Brian Aitken
  • Patent number: 12611210
    Abstract: A method for manufacturing a monofilament barbed suture. The method includes positioning a mandrel device adjacent to a rotary mount on which a razor is mounted, the mandrel device comprising a mandrel mounted to a fixture, a filament in contact with a curved surface of the mandrel; and rotating the razor with the rotary mount so that an edge of the razor impinges upon an exterior surface of the filament to impart a linear cut to the filament to a cut depth within the filament to form a barb. The mandrel has a diameter of 4 millimeters or less.
    Type: Grant
    Filed: July 8, 2025
    Date of Patent: April 28, 2026
    Assignee: Ethicon, Inc.
    Inventors: Frank Cichocki, Duru Han, Robert Scogna
  • Patent number: 12599624
    Abstract: The invention relates to a rapid setting liquid lung sealant that forms a highly adherent and elastic hydrogel. Provided are lung sealants comprising two high molecular weight (20 kDa) multi-arm PEG compositions wherein the first PEG composition includes an alkaline buffer and the second PEG composition includes a mildly acidic buffer for optimized set up time and extended working time. In some embodiments, the PEGs further comprise a radioprotectant such as tocopherol. In some embodiments, a colorant is added to one or both PEGs of the lung sealant to improve visualization of the lung sealant against human lung tissue.
    Type: Grant
    Filed: August 30, 2022
    Date of Patent: April 14, 2026
    Assignee: Ethicon, Inc.
    Inventors: Salim A. Ghodbane, Sridevi Dhanaraj, Brian Aitken
  • Patent number: 12594692
    Abstract: The present invention is directed to methods for processing absorbable, slow-to-crystallize poly(p-dioxanone) ground resin and its fines utilizing a twin-screw extruder apparatus to produce uniform pellets. Advantageously, the ground resin materials resulting from solid-state polymerization do not undergo processing, such as sieving, to remove fines from the feedstock for an extrusion and pelletizing system that has been configured with an inverted temperature profile along the extrusion barrel. The resulting PDS pellets have improved resin uniformity and greater polymer yield for improved operational efficiencies and production of extruded filaments.
    Type: Grant
    Filed: July 25, 2023
    Date of Patent: April 7, 2026
    Assignees: Ethicon, Inc., Cilag GmbH International
    Inventors: Sasa Andjelic, Jitendra Patel, Marc Wisnudel, Luke Orzechowski
  • Patent number: 12576182
    Abstract: The present invention is directed to a sealant patch for use on or over sensitive tissue, comprising: a flat, flexible, bioresorbable substrate coated by a moisture-activated adhesive on one side thereof, wherein said adhesive is at least partially inactivated in a first portion of said patch, but remains active in peripheral areas surrounding the first portion. The adherence of the first portion to the tissue is weaker versus adherence in the peripheral areas. The adhesive in the first portion is fully or partially inactivated or pre-reacted prior to application of the sealant patch to the tissue.
    Type: Grant
    Filed: August 11, 2023
    Date of Patent: March 17, 2026
    Assignee: Ethicon, Inc.
    Inventors: Sai Veruva, Leo B. Kriksunov
  • Patent number: 12576183
    Abstract: A method of making a biocompatible composition for sealing tissue includes mixing a first fluid having a first reactive component (e.g., an electrophile) and a second fluid having a second reactive component (e.g., a nucleophile) to form a mixture and expressing the mixture. During expression, a pH modifying fluid (e.g., NaOH) is added to the mixture at a rate that changes. In one embodiment, a higher ratio of the pH modifying fluid is added to the mixture during a first expressing stage and a lower ratio of said pH modifying fluid is added to the mixture during a second expressing stage. During the first expressing stage, a mixing ratio of the pH modifying fluid, the first fluid and the second fluid is 0.7-1.4:1:1. During the second expressing stage, the mixing ratio of the pH modifying fluid, the first fluid and the second fluid is 0.12-0.24:1:1.
    Type: Grant
    Filed: December 3, 2021
    Date of Patent: March 17, 2026
    Assignee: Ethicon, Inc.
    Inventors: Sridevi Dhanaraj, Salim Ghodbane, Ashley Deanglis, Michael Cardinale, Nicole Smith, Ashwin Viswanath
  • Patent number: 12577400
    Abstract: Novel compositions and systems for closure of wounds are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2-5 minutes.
    Type: Grant
    Filed: July 5, 2023
    Date of Patent: March 17, 2026
    Assignee: Ethicon, Inc.
    Inventor: Duan Li Ou
  • Patent number: 12539374
    Abstract: A system for dispensing a biocompatible reactive formulation includes a first chamber containing a first fluid having a first reactive component, a second chamber containing a second fluid having a second reactive component, and a third chamber containing a third fluid.
    Type: Grant
    Filed: February 16, 2022
    Date of Patent: February 3, 2026
    Assignee: Ethicon, Inc.
    Inventors: Jianxin Guo, Salim Ghodbane, Sridevi Dhanaraj
  • Patent number: 12528913
    Abstract: Novel compositions and systems for closure of wounds with antimicrobial effectiveness are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2-5 minutes.
    Type: Grant
    Filed: May 24, 2021
    Date of Patent: January 20, 2026
    Assignee: Ethicon, Inc.
    Inventors: Duan Li Ou, Leo Kriksunov, Julian Quintero
  • Patent number: 12514955
    Abstract: The present invention is directed to an absorbable hemostatic nonwoven patch that utilizes a biocompatible substrate comprised of melt-blown microfibers as webbed sheets that are layered and bonded/entangled in descending density and ascending porosity; with the substrate having a high flexibility, strength and porosity that is suitable for coating cross-linkable active molecules and ability for laparoscopic use or trocar deployment, ultimately for functional use as a highly effective hemostat in addressing problematic bleeding during both open and minimally invasive surgical procedures.
    Type: Grant
    Filed: July 25, 2024
    Date of Patent: January 6, 2026
    Assignee: Ethicon, Inc.
    Inventors: Sai Veruva, Jianguo Zhou, Joseph Vliet, Gerard Llanos, Kenneth Keilman